Total PSA (tPSA) level ranging from 3 ng/ml to 20 ng/ml (inclusive).
Underwent prostate MRI at the study institution with complete imaging sequences.
Capable of providing written informed consent.
Patients with PI-RADS 4-5, or PI-RADS 3 combined with PSAD ≥ 0.2 ng/ml², who have undergone prostate biopsy with no diagnosis of clinically significant prostate cancer (csPCa).
Biopsy-naïve patients with PI-RADS 2, or PI-RADS 3 combined with PSAD \< 0.2 ng/ml².
You may not be if
Pathologically confirmed diagnosis of clinically significant prostate cancer (csPCa).
Contraindications to prostate biopsy or inability to tolerate the procedure.
Current use of 5-alpha reductase inhibitors (5-ARIs).
History of hip replacement, metallic hip arthroplasty, or extensive pelvic orthopedic surgery with metallic hardware, or presence of other implants that would degrade MRI image quality.
Contraindications to bi-parametric MRI (bpMRI) (e.g., severe claustrophobia, cardiac pacemakers).
Clareo Health | Sequential bpMRI for Suspicious Prostate Lesions
